Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period.
Huh H, Kim YS, Chung W, Kim YL, Kim Y, Han S, Jung Y, Na KY, Lee KB, Oh YK, Park HC, Han SH, Yoo TH, Kim YH, Kim SW, Lee KW, Park HC, Kim SG, Kim H, Lee CH, Bae KT, Oh KH, Ahn C, Ryu HJ, Kim YC.
Huh H, et al. Among authors: kim yh, kim h, kim yl, kim sw, kim sg, kim ys, kim yc, kim y.
Kidney Res Clin Pract. 2023 Mar;42(2):216-228. doi: 10.23876/j.krcp.22.024. Epub 2023 Jan 13.
Kidney Res Clin Pract. 2023.
PMID: 36634967
Free PMC article.